OM1
Company

Last deal

$85M

Amount

Series D

Stage

16.07.2021

Date

4

all rounds

$171M

Total amount

General

About Company
OM1 is a healthcare technology company that uses real-world clinical data for medical research and personalized medicine.

Industry

Sector :

Subsector :

Also Known As

Better Outcomes

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company's outcome management platform gathers and synthesizes clinical data to provide AI-driven insights and predictions that improve clinical, financial, and operational management. OM1's intelligent data cloud for healthcare enables more precise information and better decision making for stakeholders across the healthcare ecosystem. Leveraging big data, standardized outcomes measurement, and artificial intelligence technology, OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.
Contacts

Social url